References
- Holdsworth MT, Raisch DW, Winter SS, Chavez CM. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron. Support Care Cancer 1998;6:132–8.
- Parker RI, Prakash D, Mahan RA, Giugliano DM, Atlas MP. Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children. J Pediatr Hematol Oncol 2001;23:578–81.
- Jaing TH, Tsay PK, Hung IJ, Yang CP, Hu WY. Single-dose oral granisetron versus multidose intravenous ondansetron for moderately emetogenic cyclophosphamide-based chemotherapy in pediatric outpatients with acute lymphoblastic leukemia. Pediatr Hematol Oncol 2004;21:227–35.
- Matsuo Y, Drexler HG. Establishment and characterization of human B-cell precursor leukemia cell lines. Leuk Res 1998;22:567–9.
- Tsuzuki S, Karnan S, Horibe K, Matsumoto K, Kato K, Inukai T, . Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: Analysis by means of array-based comparative genomic hybridization. Cancer Sci 2007;98:698–706.
- Sibella-Argüelles C. The proliferation of human T lymphoblastic cells induced by 5-HT1B receptors activation is regulated by 5-HT-moduline. Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie. C R Acad Sci III 2001;324:365–72.
- Behnam-Motlagh P, Sandström PE, Henriksson R, Grankvist K. Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate. J Cancer Res Clin Oncol 2002;128:449–55.
- Drozdov I, Kidd M, Gustafsson BI, Svejda B, Joseph R, Pfragner R, . Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines. Cancer 2009;115: 4934–45.